$32.44
+ $0.13 (0.40%)
End-of-day quote: 03/11/2024
NasdaqGS:CBAY
Add to Portfolio

CymaBay Therapeutics Stock Price

0
Underperform
1
2
3
4
5
6
7
8
9
10
1M 3M YTD 1Y 2Y 5Y 10Y 20Y
P/E Ratio
0.0
Market Cap
3.72B
Price-to-book Ratio
12.62
Earnings
05/10/2024
Dividend
$0.00
Div Yld
0.00%
Dividend Growth
0 Years
Beta
0.00
Short Interest
8.20%
Forecast 1Y
0.00%
Analyst Price Target
$27.73
LTG 5Y
0.00%
52 week range
$7.26 - $32.50
Country
United States